Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- Clinical Study Details
A Phase IIIb/IV, multicentre, open-label, single-arm study to investigate the efficacy and safety of faricimab (RO6867461) in patients with polypoidal choroidal vasculopathy
-
Eye Disorder -
Polypoidal Choroidal Vasculopathy (PCV)
- Results
-
Download -
Study results
LPS MR43808 Final Results July 2026 English
(PDF, 0.5 MB)
LPS MR43808 Final Results July 2026 China Chinese
(PDF, 0.8 MB)
LPS MR43808 Final Results July 2026 Hong Kong Chinese
(PDF, 0.7 MB)
LPS MR43808 Final Results July 2026 Japanese
(PDF, 0.6 MB)
LPS MR43808 Final Results July 2026 Korean
(PDF, 0.6 MB)
LPS MR43808 Final Results July 2026 Malay
(PDF, 0.4 MB)
LPS MR43808 Final Results July 2026 Malaysia Chinese
(PDF, 0.6 MB)
LPS MR43808 Final Results July 2026 Singapore Chinese
(PDF, 0.5 MB)
LPS MR43808 Final Results July 2026 Taiwan Chinese
(PDF, 0.5 MB)
LPS MR43808 Final Results July 2026 Thai
(PDF, 1.1 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com